Compare SPDR Gold Trust (GLD) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Oscar Health Inc — how do they compare? SPDR Gold Trust trades at $384.48 (market cap $139.66B), while Oscar Health Inc trades at $33.44 (market cap $10.22B). The key difference: SPDR Gold Trust is far larger — about 13.7× Oscar Health Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, SPDR Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Oscar Health Inc for 15 Days on average.
| GLD | OSCR | |
|---|---|---|
Market Cap | $139.66B | $10.22B |
Volume | 9,544,773 | 4,123,394 |
52-Week High | $495.90 | $33.81 |
52-Week Low | $362.32 | $10.85 |
Typical Hold Time | 74 Days | 15 Days |
Sector | — | Health |
Enterprise Value | — | $6.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD trades at $384.58, up 2.31% with bearish technical signals dominating. The ETF faces pressure from rising Treasury yields and a strong dollar, with technical indicators showing 17 sell signals versus 2 buy signals. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels amid Federal Reserve policy uncertainty.
The outlook remains cautious as elevated yields and dollar strength create headwinds, though some analysts see tactical opportunities near current levels. Key risks include further Fed tightening and bond market volatility, while potential catalysts include geopolitical tensions and inflation concerns. The technical setup suggests continued pressure with support at $377-$374.
OSCR trades at $33.37, up 1.4% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, turning profitable with $551M net income. Recent Q1 and Q2 2026 earnings beat expectations, while analyst consensus leans toward Hold (61.54%) with a $34 price target. Technical indicators show bullish signals but RSI suggests potential overbought conditions near-term.
Outlook remains positive with scalable ACA market growth and margin expansion driving earnings potential. Key risks include rising medical costs threatening profitability and competitive pressures. The stock offers growth exposure but requires monitoring of execution on 2029 EPS targets of $4+ and medical loss ratio management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
